Flash Glucose Monitoring Segmentation
End-user (Hospitals, Clinics, Academic & Research Institutes)
The global flash glucose monitoring market is segmented and analyzed for demand and supply by end-user into hospitals, clinics, academic & research institutes, and others. Amongst these, the hospitals segment is anticipated to capture the largest market size over the forecast period owing to the growing healthcare infrastructure, rising number of diabetic patient’s visits to hospitals, and escalating healthcare expenditure. According to data from the World Bank, worldwide healthcare spending increased by 9.83% in 2019.
Our in-depth analysis of the global flash glucose monitoring market includes the following segments:
|
By Modality |
|
|
By Application |
|
|
By Technology |
|
|
By End-User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of flash glucose monitoring is evaluated at USD 16.61 million.
The flash glucose monitoring market size was over USD 15.53 million in 2024 and is projected to reach USD 45.94 million by 2037, growing at around 8.7% CAGR during the forecast period i.e., between 2025-2037. Worldwide rising incidences of chronic diseases, and growing improvement in glycemia in higher risk patients with the use of flash glucose monitoring, will drive the market growth.
North America industry is estimated to hold largest revenue share of 40% by 2037, backed by changing lifestyle, rising prevalence of obesity, rising healthcare expenditure, and increasing cases of diabetes in the region
The major players in the market are Novo Nordisk A/S, DexCom, Inc., GlySens Incorporated, Medtronic plc, Insulet Corporation, Ypsomed Holding AG, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Tandem Diabetes Care, Inc., ForaCare, Inc.
